177 related articles for article (PubMed ID: 17296751)
1. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
[TBL] [Abstract][Full Text] [Related]
2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
3. Further Characterization of the Capsule-Like Complex (CLC) Produced by
Champion AE; Bandara AB; Mohapatra N; Fulton KM; Twine SM; Inzana TJ
Front Cell Infect Microbiol; 2018; 8():182. PubMed ID: 29963499
[No Abstract] [Full Text] [Related]
4. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.
Chen L; Valentine JL; Huang CJ; Endicott CE; Moeller TD; Rasmussen JA; Fletcher JR; Boll JM; Rosenthal JA; Dobruchowska J; Wang Z; Heiss C; Azadi P; Putnam D; Trent MS; Jones BD; DeLisa MP
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3609-18. PubMed ID: 27274048
[TBL] [Abstract][Full Text] [Related]
5. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB;
Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854
[TBL] [Abstract][Full Text] [Related]
6. A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain.
Matz LM; Petrosino JF
Microbiologyopen; 2021 Feb; 10(2):e1170. PubMed ID: 33970545
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
[TBL] [Abstract][Full Text] [Related]
8. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
[TBL] [Abstract][Full Text] [Related]
9. Francisella tularensis tmRNA system mutants are vulnerable to stress, avirulent in mice, and provide effective immune protection.
Svetlanov A; Puri N; Mena P; Koller A; Karzai AW
Mol Microbiol; 2012 Jul; 85(1):122-41. PubMed ID: 22571636
[TBL] [Abstract][Full Text] [Related]
10. The rLVS Δ
Mlynek KD; Cline CR; Biryukov SS; Toothman RG; Bachert BA; Klimko CP; Shoe JL; Hunter M; Hedrick ZM; Dankmeyer JL; Mou S; Fetterer DP; Qiu J; Lee ED; Cote CK; Jia Q; Horwitz MA; Bozue JA
Hum Vaccin Immunother; 2023 Dec; 19(3):2277083. PubMed ID: 37975637
[No Abstract] [Full Text] [Related]
11. Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence.
Bakshi CS; Malik M; Regan K; Melendez JA; Metzger DW; Pavlov VM; Sellati TJ
J Bacteriol; 2006 Sep; 188(17):6443-8. PubMed ID: 16923916
[TBL] [Abstract][Full Text] [Related]
12. A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
Whelan AO; Flick-Smith HC; Walker NJ; Abraham A; Levitz SM; Ostroff GR; Oyston PCF
PLoS One; 2024; 19(5):e0294998. PubMed ID: 38713688
[TBL] [Abstract][Full Text] [Related]
13. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.
Pechous RD; McCarthy TR; Zahrt TC
Microbiol Mol Biol Rev; 2009 Dec; 73(4):684-711. PubMed ID: 19946137
[TBL] [Abstract][Full Text] [Related]
14. Mutation of
Mlynek KD; Toothman RG; Martinez EE; Qiu J; Richardson JB; Bozue JA
Microbiology (Reading); 2024 Feb; 170(2):. PubMed ID: 38421161
[TBL] [Abstract][Full Text] [Related]
15. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.
Zarrella TM; Singh A; Bitsaktsis C; Rahman T; Sahay B; Feustel PJ; Gosselin EJ; Sellati TJ; Hazlett KR
PLoS One; 2011; 6(7):e22335. PubMed ID: 21799828
[TBL] [Abstract][Full Text] [Related]
16. An AraC/XylS Family Transcriptional Regulator Modulates the Oxidative Stress Response of Francisella tularensis.
Marghani D; Ma Z; Centone AJ; Huang W; Malik M; Bakshi CS
J Bacteriol; 2021 Nov; 203(23):e0018521. PubMed ID: 34543107
[TBL] [Abstract][Full Text] [Related]
17. Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
Whelan AO; Flick-Smith HC; Homan J; Shen ZT; Carpenter Z; Khoshkenar P; Abraham A; Walker NJ; Levitz SM; Ostroff GR; Oyston PCF
PLoS One; 2018; 13(10):e0200213. PubMed ID: 30296254
[TBL] [Abstract][Full Text] [Related]
18. ThioredoxinA1 Controls the Oxidative Stress Response of Francisella tularensis Live Vaccine Strain (LVS).
Ma Z; Higgs M; Alqahtani M; Bakshi CS; Malik M
J Bacteriol; 2022 May; 204(5):e0008222. PubMed ID: 35475633
[TBL] [Abstract][Full Text] [Related]
19. Vaccines against tularemia.
Barry EM; Cole LE; Santiago AE
Hum Vaccin; 2009 Dec; 5(12):832-8. PubMed ID: 19923904
[TBL] [Abstract][Full Text] [Related]
20. Tularemia.
Ellis J; Oyston PC; Green M; Titball RW
Clin Microbiol Rev; 2002 Oct; 15(4):631-46. PubMed ID: 12364373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
